Boehringer Ingelheim Aims A Shot At India’s Booming OTC Market
This article was originally published in PharmAsia News
Executive Summary
The family-controlled German drug maker is preparing an entry into the Indian consumer health care segment, a market seeing a flurry of activity from its global competitors like GSK and Sanofi.
You may also be interested in...
Long Search Ends For Sanofi As It Buys Universal Medicare's Nutraceutical Brands In India
MUMBAI - French drug maker Sanofi's long search for high-growth OTC brands in India finally materialized as it announced the acquisition of Mumbai-headquartered Universal Medicare Pvt. Ltd.'s nutraceutical businesses
Indian Drug Regulator Softens Stand On Emergency Contraceptive Pills; Ad Campaigns On As Doctors Advise Caution
MUMBAI - Less than six months after the Drug Controller General of India clamped a ban over mass media advertisements of popular oral emergency contraceptive I-pill, the segment leader that changed hands from Cipla to Piramal Healthcare is aggressively back on national television channels with frequent time spots
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.